Overview
Zong-han Li practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Leydig Cell Testicular Tumor, Sertoli-Leydig Cell Tumor, Epispadias, Precocious Puberty, and Orchiectomy.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zong-han Li
Is Zong-han Li a top-rated expert for Leydig Cell Testicular Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Zong-han Li is classified as an Experienced expert for Leydig Cell Testicular Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zong-han Li participate in research or clinical trials?
Yes. Zong-han Li has published 8 articles and abstracts on conditions like Leydig Cell Testicular Tumor. You can view a list of Zong-han Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EpispadiasLi isExperienced. Learn about Epispadias.
- Leydig Cell Testicular Tumor
- OrchiectomyLi isExperienced. Learn about Orchiectomy.
- Precocious PubertyLi isExperienced. Learn about Precocious Puberty.
- Sertoli-Leydig Cell Tumor